Apellis Pharmaceuticals Inc EMPAVELI FDA Approval Call Transcript
Good morning. My name is Catherine, and I will be your conference operator today. At this time, I would like to welcome everyone to the Apellis Pharmaceuticals conference call. For those of you participating via conference call, a slide presentation has been made available via webcast and will be posted to the Investor page of the company's website, www.apellis.com, at the conclusion of the call today. (Operator Instructions) Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Ms. Tracy Vineis, Vice President of Communications. Please proceed.
Thank you for joining us today to discuss the FDA approval of Empaveli, also known as Pegcetacoplan. With me on the call are Co-Founder and Chief Executive Officer, Dr. Cedric Francois; Chief Medical Officer, Dr. Federico Grossi; Chief Commercial Officer, Adam Townsend; and Chief Financial Officer, Tim Sullivan, who will be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |